Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation

NCT01842334 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT01842334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01842334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation
Lead sponsor
Mclean Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
April 30, 2013
Completion date
August 31, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, smoking cessation